Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1101|33|1|21-28

ISSN： 0733-2459

Source： JOURNAL OF CLINICAL APHERESIS, Vol.33, Iss.1, 2018-02, pp. : 21-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 409-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 763-772

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 5, 2010-05 ,pp. : 886-891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 494-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 504-514

John Wiley & Sons Inc

Access to resources Recommend Favorite